Asia · Regional markets · Vietnam Investment Review

Zuellig Pharma Acquires Hangzhou Facility to Expand Chinese Clinical Sourcing

Published by Vietnam Investment Review · Vietnam 13 h ago

Healthcare distribution firm Zuellig Pharma acquired a licensed facility in Hangzhou to establish local clinical trial supply and sourcing capabilities across mainland China.

Read the full article on Vietnam Investment Review Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (vir.com.vn)

Also worth reading

Mint

TSX posts steepest decline in five months as US tech rout hits Canadian shares

CNBC-TV18

Lemon Tree Hotels Q2 Results: Net profit surges 64% to ₹57 crore, revenue up 18%

Business Standard

Zuellig Pharma Acquires Hangzhou Facility to Expand Chinese Clinical Sourcing

Share

Also worth reading

TSX posts steepest decline in five months as US tech rout hits Canadian shares

Lemon Tree Hotels Q2 Results: Net profit surges 64% to ₹57 crore, revenue up 18%

Early Diwali cheer: Markets see fireworks; rupee rises, bond yields ease

Ex-Cathay Cineplex operator mm2 Asia’s restructuring scheme gets creditors’ OK

9th China International Import Expo opens in Shanghai

Aletheia Capital keeps faith in Wilmar as weak Brazilian real should crush margins